This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n15http://linked.opendata.cz/resource/domain/vavai/subjekt/
n10http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n17http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00098892%3A_____%2F13%3A%230000471%21RIV14-MZ0-00098892/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n16http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n13http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00098892%3A_____%2F13%3A%230000471%21RIV14-MZ0-00098892
rdf:type
skos:Concept n10:Vysledek
dcterms:description
The Czech national registry ATTRA collects data from patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and juvenile idiopathic arthritis, treated with the biologic drugs. ATTRA is a prospective centralized computerized registry of patients with a focus on efficacy, safety, and quality of life data. Abatacept is approved as a second-line agent which can be prescribed after a failure of at least one TNF-alfa inhibitor. Data of patients treated with abatacept has been collected since 2008. The Czech national registry ATTRA collects data from patients with rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and juvenile idiopathic arthritis, treated with the biologic drugs. ATTRA is a prospective centralized computerized registry of patients with a focus on efficacy, safety, and quality of life data. Abatacept is approved as a second-line agent which can be prescribed after a failure of at least one TNF-alfa inhibitor. Data of patients treated with abatacept has been collected since 2008.
dcterms:title
Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry
skos:prefLabel
Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic - data from the ATTRA registry
skos:notation
RIV/00098892:_____/13:#0000471!RIV14-MZ0-00098892
n10:predkladatel
n15:ico%3A00098892
n3:aktivita
n16:V n16:I
n3:aktivity
I, V
n3:cisloPeriodika
10
n3:dodaniDat
n13:2014
n3:domaciTvurceVysledku
n14:6386911
n3:druhVysledku
n4:J
n3:duvernostUdaju
n8:S
n3:entitaPredkladatele
n17:predkladatel
n3:idSjednocenehoVysledku
59210
n3:idVysledku
RIV/00098892:_____/13:#0000471
n3:jazykVysledku
n7:eng
n3:klicovaSlova
abatacept, registry, rheumatoid arthritis
n3:klicoveSlovo
n11:rheumatoid%20arthritis n11:abatacept n11:registry
n3:kodStatuVydavatele
CZ - Česká republika
n3:kontrolniKodProRIV
[7E83DE89F62E]
n3:nazevZdroje
Clinical Rheumatology
n3:obor
n12:FE
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
5
n3:rokUplatneniVysledku
n13:2013
n3:svazekPeriodika
32
n3:tvurceVysledku
Smržová, Andrea
s:issn
0770-3198
s:numberOfPages
8